Skip to content

Virtual Reality-based ReMind device on upper limb dysfunction in stroke

Efficacy of Virtual Reality-based ReMind device on upper limb dysfunction in stroke: A randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077344
Enrollment
92
Registered
2024-11-25
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I69- Sequelae of cerebrovascular disease

Interventions

Intervention1: Virtual Reality + Conventional Physiotherapy: The experimental group will now receive 1 hour of home-based therapy comprising of 30 minutes of VR therapy and 30 minutes of conventional

Sponsors

Indian Council of Medical Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 to 75 years Stroke onset greater than or equal to 3 months to less than 3 years a diagnosis of stroke (haemorrhage or ischemia) confirmed through CT or MRI MoCA greater than or equal to 18, ability to understand simple instructions MAS score for spasticity ranging from 0 to 3, with the capability to perform VR exercises able to sit independently for at least 60 minutes Willingness to participate and sign an informed consent

Exclusion criteria

Exclusion criteria: i) Uncorrected auditory or visual disorder which is limiting the use of Virtual Reality headset. ii) Musculoskeletal injury/ fracture in affected UE in the past 6 months that limit or restrict range of motion iii) surgical wound or implants or surgical procedure like craniotomy. iv) any uncontrolled or unstable medical condition, or other neurological disorder such as seizures. v) any other impairment limiting the use of VR system

Design outcomes

Primary

MeasureTime frame
Change in FMA Score at 1 month from baseline Timepoint: Change in FMA Score at 1 month from baseline

Secondary

MeasureTime frame
Change in FMA Score at 3 months from baseline Timepoint: Change in FMA Score at 3 months from baseline ;Action research arm test (ARAT) at 1 & 3 months from baselineTimepoint: Action research arm test (ARAT) at 1 & 3 months from baseline;Modified Ashworth scale (MAS) at 1 & 3 months from baselineTimepoint: Modified Ashworth scale (MAS) at 1 & 3 months from baseline;Modified Functional Reach Test (mFRT) at 1 & 3 months from baseline Timepoint: Modified Functional Reach Test (mFRT) at 1 & 3 months from baseline ;Addenbrookes Cognitive Examination at 1 & 3 months from baselineTimepoint: Addenbrookes Cognitive Examination at 1 & 3 months from baseline;Stroke Impact Scale at 1 & 3 months from baselineTimepoint: Stroke Impact Scale at 1 & 3 months from baseline;MRC scale for strength at 1 & 3 months from baseline Timepoint: MRC scale for strength at 1 & 3 months from baseline ;Function is Sitting test (FIST) at 1 & 3 months from baselineTimepoint: Function is Sitting test (FIST) at 1 & 3 months from baseline;Frenchay Aphasia Screen Test (FAST) at 1 & 3 months from baselineTimepoint: Frenchay Aphasia Screen Test (FAST) at 1 & 3 months from baseline;SF-36 at 1 & 3 months from baselineTimepoint: SF-36 at 1 & 3 months from baseline;MRS at 1 & 3 months from baselineTimepoint: MRS at 1 & 3 months from baseline

Countries

India

Contacts

Public ContactVishnu V Y

All India Institute Of Medical Sciences

vishnuvy16@yahoo.com9855480361

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 9, 2026